Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2020

Open Access 01-12-2020 | Bronchial Asthma | Review

The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma

Authors: Jing Zhang, Zhenxing Zhu, Xu Zuo, He Pan, Yinuo Gu, Yuze Yuan, Guoqiang Wang, Shiji Wang, Ruipeng Zheng, Zhongmin Liu, Fang Wang, Jingtong Zheng

Published in: Respiratory Research | Issue 1/2020

Login to get access

Abstract

Asthma is a complex heterogeneous disease. The neutrophilic subtypes of asthma are described as persistent, more severe and corticosteroid-resistant, with higher hospitalization and mortality rates, which seriously affect the lives of asthmatic patients. With the development of high-throughput sequencing technology, an increasing amount of evidence has shown that lower airway microbiome dysbiosis contributes to the exacerbation of asthma, especially neutrophilic asthma. Nontypeable Haemophilus influenzae is normally found in the upper respiratory tract of healthy adults and is one of the most common strains in the lower respiratory tract of neutrophilic asthma patients, in whom its presence is related to the occurrence of corticosteroid resistance. To understand the pathogenic mechanism by which nontypeable Haemophilus influenzae colonization leads to the progression of neutrophilic asthma, we reviewed the previous literature on nontypeable Haemophilus influenzae colonization and subsequent aggravation of neutrophilic asthma and corticosteroid resistance. We discussed nontypeable Haemophilus influenzae as a potential therapeutic target to prevent the progression of neutrophilic asthma.
Literature
1.
Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16:45–56.PubMed
2.
Reddel HK, Bateman ED, Allan B, Louis-Philippe B, Cruz AA, Drazen JM, Tari H, Hurd SS, Hiromasa I, de Jongste Johan C, Lemanske RF, Levy ML, O'Byrne PM, Pierluigi P, Pedersen SE, Emilio P, Manuel S-Q, Szefler SJ, Wong Gary WK, Mark FGJ. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46:622–39.PubMedPubMedCentral
3.
Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54–61.PubMed
4.
McCann JR, Mason SN, Auten RL, St. Geme JW, Seed PC. Early-life intranasal colonization with nontypeable Haemophilus influenzae exacerbates juvenile airway disease in mice. Infect Immun. 2016;84:2022–30.PubMedPubMedCentral
5.
Peters, Michael C., Sheena Kerr, Eleanor M. Dunican, Prescott G. Woodruff, Merritt L. Fajt, Bruce D. Levy, Elliot Israel, Brenda R. Phillips, David T. Mauger, Suzy A. Comhair, Serpil C. Erzurum, Mats W. Johansson, Nizar N. Jarjour, Andrea M. Coverstone, Mario Castro, Annette T. Hastie, Eugene R. Bleecker, Sally E. Wenzel, and John V. Fahy. 2019. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 143: 104–113.e114.
6.
Hansbro PM, Kim RY, Starkey MR, Donovan C, Dua K, Mayall JR, Liu G, Hansbro NG, Simpson JL, Wood LG, Hirota JA, Knight DA, Foster PS, Horvat JC. Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. Immunol Rev. 2017;278:41–62.PubMed
7.
Liu AH. Revisiting the hygiene hypothesis for allergy and asthma. J Allergy Clin Immunol. 2015;136:860–5.PubMed
8.
Bonamichi-Santos R, Aun MV, Agondi RC, Kalil J, Giavina-Bianchi P. Microbiome and asthma: what have experimental models already taught us? J Immunol Res. 2015;2015:614758.PubMedPubMedCentral
9.
Lu J, Xiong L, Zhang X, Liu Z, Wang S, Zhang C, Zheng J, Wang G, Zheng R, Simpson JL, Wang F. The role of lower airway dysbiosis in asthma: Dysbiosis and asthma. Mediat Inflamm. 2017;2017:1–10.
10.
Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WOC. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5:e8578.PubMedPubMedCentral
11.
Simpson JL, Daly J, Baines KJ, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Hugenholtz P, Willner D, Gibson PG. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J. 2015;47:792–800.PubMed
12.
Van Eldere J, Slack MPE, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014;14:1281–92.PubMed
13.
Gessner BD, Adegbola RA. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine. 2008;26:B3–8.PubMed
14.
Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Simpson JL, Rogers GB. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018;141:94–103 e115.PubMed
15.
Yang, Xu, Yunqiu Jiang, and Changzheng Wang. 2016. Does IL-17 respond to the disordered lung microbiome and contribute to the neutrophilic phenotype in asthma? Mediat Inflamm 2016: 1–7.
16.
Allen S, Zaleski A, Johnston JW, Gibson BW, Apicella MA. Novel sialic acid transporter of Haemophilus influenzae. Infect Immun. 2005;73:5291–300.PubMedPubMedCentral
17.
Toropainen M, Raitolehto A, Henckaerts I, Wauters D, Poolman J, Lestrate P, Käyhty H. Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D. Infect Immun. 2008;76:4546–53.PubMedPubMedCentral
18.
Kenjale R, Meng G, Fink DL, Juehne T, Ohashi T, Erickson HP, Waksman G, St Geme JW. Structural determinants of autoproteolysis of the Haemophilus influenzae hap autotransporter. Infect Immun. 2009;77:4704–13.PubMedPubMedCentral
19.
Murphy TF, Lesse AJ, Kirkham C, Zhong H, Sethi S, Munson RS. A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease. PLoS One. 2011;6:e25923.PubMedPubMedCentral
20.
Murphy TF, Kirkham C, Jones MM, Sethi S, Kong Y, Pettigrew MM. Expression of IgA proteases by Haemophilus influenzae in the respiratory tract of adults with chronic obstructive pulmonary disease. J Infect Dis. 2015;212:1798–805.PubMedPubMedCentral
21.
Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, Greenberg SB. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med. 2001;164:2114–9.PubMed
22.
Weiser JN, Pan N. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol Microbiol. 1998;30:767–75.PubMed
23.
Clementi CF, Håkansson AP, Murphy TF. Internalization and trafficking of nontypeable Haemophilus influenzae in human respiratory epithelial cells and roles of IgA1 proteases for optimal invasion and persistence. Infect Immun. 2014;82:433–44.PubMedPubMedCentral
24.
Shukla SD, Fairbairn RL, Gell DA, Latham R, Sohal SS, Walters H, O’Toole R. An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke. Int J Chronic Obstructive Pulmonary Disease. 2016;11:1647–55.
25.
Clementi CF, Murphy TF. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol. 2011;1:1.PubMedPubMedCentral
26.
King PT, Sharma R. The lung immune response to nontypeable Haemophilus influenzae (lung immunity to NTHi). J Immunol Res. 2015;2015:706376.PubMedPubMedCentral
27.
Essilfie A-T, Simpson JL, Horvat JC, Preston JA, Dunkley ML, Foster PS, Gibson PG, Hansbro PM. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 2011;7:e1002244.PubMedPubMedCentral
28.
Jurcisek JA, Brockman KL, Novotny LA, Goodman SD, Bakaletz LO. Nontypeable haemophilus influenzae releases DNA and DNABII proteins via a T4SS -like complex and ComE of the type IV pilus machinery. Proc Natl Acad Sci. 2017;114:201705508.
29.
Wang B, Lim DJ, Han J, Kim YS, Basbaum CB, Li J-D. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem. 2002;277:949–57.PubMed
30.
McNamara N, Gallup M, Khong A, Sucher A, Maltseva I, Fahy J, Basbaum C. Adenosine up-regulation of the mucin gene, MUC2, in asthma. FASEB J. 2004;18:1770–2.PubMed
31.
Jono H, Shuto T, Xu H, Kai H, Lim DJ, Gum JR, Kim YS, Yamaoka S, Feng X-H, Li J-D. Transforming growth factor-β-smad signaling pathway cooperates with NF-κB to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem. 2002;277:45547–57.PubMed
32.
Andreadis, Athena A., Stanley L. Hazen, Suzy A. A. Comhair, and Serpil C. Erzurum. 2003. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213–225.
33.
Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005;202:47–59.PubMedPubMedCentral
34.
Nadeem A, Siddiqui N, Al-Harbi NO, Al-Harbi MM, Ahmad SF. TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma. Int J Biochem Cell Biol. 2016;73:53–62.PubMed
35.
Liu Q, Gao Y, Ci X. Role of Nrf2 and its activators in respiratory diseases. Oxidative Med Cell Longev. 2019;2019:1–17.
36.
King PT, Sharma R, O’Sullivan K, Selemidis S, Lim S, Radhakrishna N, Lo C, Prasad J, Callaghan J, McLaughlin P, Farmer M, Steinfort D, Jennings B, Ngui J, Broughton BRS, Thomas B, Essilfie A-T, Hickey M, Holmes PW, Hansbro P, Bardin PG, Holdsworth SR. Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS One. 2015;10:e0120371.PubMedPubMedCentral
37.
Harrison A, Baker BD, Munson RS. Overlapping and complementary oxidative stress defense mechanisms in nontypeable Haemophilus influenzae. J Bacteriol. 2015;197:277–85.PubMed
38.
Harrison A, Bakaletz LO, Munson RS. Haemophilus influenzae and oxidative stress. Front Cell Infect Microbiol. 2012;2:40.PubMedPubMedCentral
39.
Wong C, Jones S. Oxidative stress and macrolides in bronchiectasis - exhaling few clues. Respirology. 2013;18:1037–8.PubMed
40.
Cho YS, Moon H-B. The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2010;2:183–7.PubMedPubMedCentral
41.
Hardy GG, Tudor SM, Geme JWS. The pathogenesis of disease due to nontypeable Haemophilus influenzae. Methods Molecular Med. 2003;71:1–28.
42.
Kumari A, Singh DK, Dash D, Singh R. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrixmetalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model. Inflammopharmacology. 2018;27:731–48.PubMed
43.
Comhair SAA, Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2010;12:93–124.PubMedPubMedCentral
44.
Reddel HK, Levy ML. The GINA asthma strategy report: What’s new for primary care? NPJ Primary Care Respiratory Medicine. 2015;25:15050.PubMedPubMedCentral
45.
Won J, Gil CH, Jo A, Kim HJ. Inhaled delivery of interferon-lambda restricts epithelial-derived Th2 inflammation in allergic asthma. Cytokine. 2019;119:32–6.PubMed
46.
Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716–25.PubMed
47.
Berker M, Frank LJ, Geßner AL, Grassl N, Holtermann AV, Höppner S, Kraef C, Leclaire MD, Maier P, Messerer DAC, Möhrmann L, Nieke JP, Schoch D, Soll D, Woopen CMP. Allergies – a T cells perspective in the era beyond the TH1/TH2 paradigm. Clin Immunol. 2017;174:73–83.PubMed
48.
Hirose K, Iwata A, Tamachi T, Nakajima H. Allergic airway inflammation: key players beyond the Th2 cell pathway. Immunol Rev. 2017;278:145–61.PubMed
49.
Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med. 2009;180:720–30.PubMedPubMedCentral
50.
Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol. 2013;6:335–46.PubMed
51.
Guan X, Lu Y, Wang G, Gibson P, Chen F, Fang K, Wang Z, Pang Z, Guo Y, Lu J, Yuan Y, Ran N, Wang F. The role of regulatory T cell in nontypeable Haemophilus influenzae-induced acute exacerbation of chronic obstructive pulmonary disease. Mediat Inflamm. 2018;2018:1–14.
52.
Zhu L, Ciaccio CE, Casale TB. Potential new targets for drug development in severe asthma. World Allergy Organization Journal. 2018;11:30.PubMed
53.
Webley WC, Hahn DL. Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides. Respir Res. 2017;18:98.PubMedPubMedCentral
54.
Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt ME, Mattoli S. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol. 2012;5:140–9.PubMed
55.
Tan H-TT, Hagner S, Ruchti F, Radzikowska U, Tan G, Altunbulakli C, Eljaszewicz A, Moniuszko M, Akdis M, Akdis CA, Garn H, Sokolowska M. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2018;74:294–307.PubMed
56.
Al-Alwan LA, Chang Y, Baglole CJ, Risse P-A, Halayko AJ, Martin JG, Eidelman DH, Hamid Q. Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17–induced growth-related oncogenes. J Allergy Clin Immunol. 2012;130:977–85 e976.PubMed
57.
Chang Y, Al-Alwan L, Risse P-A, Halayko AJ, Martin JG, Baglole CJ, Eidelman DH, Hamid Q. Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J. 2012;26:5152–60.PubMed
58.
Loubaki L, Hadj-Salem I, Fakhfakh R, Jacques E, Plante S, Boisvert M, Aoudjit F, Chakir J. Co-culture of human bronchial fibroblasts and CD4+ T cells increases Th17 cytokine signature. PLoS One. 2013;8:e81983.PubMedPubMedCentral
59.
Wang F, He XY, Baines KJ, Gunawardhana LP, Simpson JL, Li F, Gibson PG. Different inflammatory phenotypes in adults and children with acute asthma. Eur Respir J. 2011;38:567–74.PubMed
60.
Ramadan AA, Gaffin JM, Israel E, Phipatanakul W. Asthma and corticosteroid responses in childhood and adult asthma. Clin Chest Med. 2019;40:163–77.PubMedPubMedCentral
61.
Goleva E, Harris JK, Robertson CE, Jackson LP, Martin RJ, Leung DYM. Airway microbiome and responses to corticosteroids in corticosteroid-resistant asthma patients treated with acid suppression medications. J Allergy Clin Immunol. 2017;140:860–2 e861.PubMed
62.
Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, Good JT, Gelfand EW, Martin RJ, Leung DYM. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013;188:1193–201.PubMedPubMedCentral
63.
McKinley L, Alcorn JF, Peterson A, DuPont RB, Kapadia S, Logar A, Henry A, Irvin CG, Piganelli JD, Ray A, Kolls JK. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181:4089–97.PubMedPubMedCentral
64.
Zijlstra GJ, ten Hacken N, Hoffmann R, van Oosterhout AJM, Heijink IH. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur Respir J. 2012;39:439–45.PubMed
65.
Vazquez-Tello A, Semlali A, Jamila C, Martin JG, Dexter L, Eidelman DH, Hamid Q. Induction of glucocorticoid receptor-β expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy. 2010;40:1312–22.PubMed
66.
Bhavsar PK, Hew M, Nematolla K, Torrego A, Barnes PJ, Adcock IM, Chung KF. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax. 2008;63:784–90.PubMed
67.
Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med. 2006;174:134–41.PubMedPubMedCentral
68.
Araki N, Yanagihara K, Morinaga Y, Yamada K, Nakamura S, Yamada Y, Kohno S, Kamihira S. Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells. Eur J Pharmacol. 2010;644:209–14.PubMed
69.
Semic-Jusufagic A, Belgrave D, Pickles A, Telcian AG, Bakhsoliani E, Sykes A, Simpson A, Johnston SL, Custovic A. Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study. Lancet Respir Med. 2014;2:621–30.PubMed
70.
Chen IL, Huang H-C, Chang Y-H, Huang H-Y, Yeh W-J, Wu T-Y, Suen J-L, Yang S-N, Hung C-H. Effect of antibiotic use for acute bronchiolitis on new-onset asthma in children. Sci Rep. 2018;8:6090.PubMedPubMedCentral
71.
Donovan BM, Abreo A, Tan D, Gebretsadik T, Turi KN, Yu C, Ding J, Dupont WD, Stone CA, Hartert TV, Pingsheng W. Dose, timing, and type of infant antibiotic use and the risk of childhood asthma. Clin Infect Dis. 2019. https://​doi.​org/​10.​1093/​cid/​ciz448.
72.
Loewen K, Monchka B, Mahmud SM, Jong GT, Azad MB. Prenatal antibiotic exposure and childhood asthma: a population-based study. Eur Respir J. 2018;52:1702070.PubMed
73.
Hodge S, Tran HB, Hamon R, Roscioli E, Hodge G, Jersmann H, Ween M, Reynolds PN, Yeung A, Treiberg J, Wilbert S. Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases. Am J Phys Lung Cell Mol Phys. 2017;312:L678–87.
74.
Konduru AS, Lee B-C, Li J-D. Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway. Sci Rep. 2016;6:31695.PubMedPubMedCentral
75.
Zhu T, Chen Z, Chen G, Wang D, Tang S, Deng H, Wang J, Li S, Lan J, Tong J, He L, Deng X, Zhang W, Sun J, Yuesheng T, Luo W, Li C. Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPARγ-dependent NF-κB signaling pathway in vivo and in vitro. Mediat Inflamm. 2019;2019:4927430.
76.
Akiba T, Morikawa T, Odaka M, Nakada T, Kamiya N, Yamashita M, Yabe M, Inagaki T, Asano H, Mori S, Tsukamoto Y, Urashima M. Vitamin D supplementation and survival of patients with non–small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res. 2018;24:4089–97.PubMed
77.
Schapochnik, Adriana, Marcia R. da Silva, Mayara P. Leal, Janete Esteves, Cristina B. Hebeda, Silvana Sandri, Daniela D. F. T. da Silva, Sandra H. P. Farsky, Rodrigo L. Marcos, and Adriana Lino-dos-Santos-Franco. 2018. Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis. Toxicol Appl Pharmacol 355: 60–67.
78.
Huang Y, Wang L, Jia X-X, Lin X-X, Zhang W-X. Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway. Int Immunopharmacol. 2019;68:88–94.PubMed
79.
Wang M, Liu M, Wang C, Xiao Y, An T, Zou M, Cheng G. Association between vitamin D status and asthma control: a meta-analysis of randomized trials. Respir Med. 2019;150:85–94.PubMed
80.
Yu-Ying Q, Xiao-Yan Z, Xiu-Fen Q, Wu Y-X, Chu Q, Tao B. 1,25-dihydroxyvitamin D3 reduces mouse airway inflammation of neutrophilic asthma by transcriptional modulation of interleukin-17A. Am J Transl Res. 2017;9:5411–21.
81.
Chambers ES, Nanzer AM, Pfeffer PE, Richards DF, Timms PM, Martineau AR, Griffiths CJ, Corrigan CJ, Hawrylowicz CM. Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: potential benefits of calcitriol. J Allergy Clin Immunol. 2015;136:628–37 e624.PubMedPubMedCentral
82.
Bakaletz LO, Novotny LA. Nontypeable Haemophilus influenzae (NTHi). Trends Microbiol. 2018;26:727–8.PubMed
83.
Clarke C, Bakaletz LO, Ruiz-Guiñazú J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Review Vaccines. 2017;16:751–64.
84.
Zhang W, Zhang X, Sheng A, Weng C, Zhu T, Li C, Zhao W. Gamma-secretase inhibitor alleviates acute airway inflammation of allergic asthma in mice by down-regulating Th17 cell differentiation. J Allergy Clin Immunol. 2015;135:AB225.
85.
Kianmehr M, Haghmorad D, Nosratabadi R, Rezaei A, Alavinezhad A, Boskabady MH. The effect of Zataria multiflora on Th1/Th2 and Th17/T regulatory in a mouse model of allergic asthma. Front Pharmacol. 2017;8:458.PubMedPubMedCentral
86.
Morishima Y, Ano S, Ishii Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Hizawa N. Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma. Clin Dev Immunol. 2013;2013:1–9.
87.
Busse WW, Holgate S, Kerwin E, Chon Y, Feng JY, Lin J, Lin S-L. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti–IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013;188:1294–302.PubMed
88.
Clancy R, Murree-Allen K, Cripps A, Yeung S, Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet. 1985;326:1395–7.
89.
Clancy RL, Dunkley M. Acute exacerbations in COPD and their control with oral immunization with non-typeable Haemophilus influenzae. Front Immunol. 2011;2:7.PubMedPubMedCentral
90.
Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M, Boschetto P, Strange RC, Hemmingsen A, Spiteri MA. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol. 2002;109:867–72.PubMed
91.
Duan L, Li J, Ma P, Xu Y, Shunqing X. Vitamin E antagonizes ozone-induced asthma exacerbation in Balb/c mice through the Nrf2 pathway. Food Chem Toxicol. 2017;107:47–56.PubMed
92.
Emilie S, Anna C, Ignacio G-D, Giao D, Camille H, Canelle M, Catherine D, Carolyn H, Ingram John R, Luigi N, Olivier C, Laurence LC. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2017;12:CD011535.
93.
Kenneth V, Frank P, Harald B, Juan L, Dries VR, Ann D, Isabel V, Kris P, Jan T, Lambrecht Bart N, Hamida H, Hans DW, Rudi B, Guy L, Savvides SN. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun. 2017;8:14937.
94.
Corren Jonathan, Parnes Jane R, Wang Liangwei, Mo May, Roseti Stephanie L, Griffiths Janet M, and van der Merwe René. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377:936–46.
95.
He Y, Jingjing S, Tam NQ, Erli Y, Hongbo L, Xin R, Wu Z, Jianshuang L, Wenli Q, Kean KS, Yang T, Wei Y, Feng S, Zhijian X, Xiaozhu H, Karsten M, Booki M, Eric XH. Development of highly potent glucocorticoids for steroid-resistant severe asthma. Proc Natl Acad Sci U S A. 2019;116:6932–7.PubMedPubMedCentral
96.
O'Byrne Paul M, Hristo M, Margareta P, Kai R, Christina K, Mohib U, Bengt L, Marie C, Parameswaran N. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016;4:797–806.PubMed
Metadata
Title
The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma
Authors
Jing Zhang
Zhenxing Zhu
Xu Zuo
He Pan
Yinuo Gu
Yuze Yuan
Guoqiang Wang
Shiji Wang
Ruipeng Zheng
Zhongmin Liu
Fang Wang
Jingtong Zheng
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01438-5

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue

Research

Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort

Research

Nasal microbiota dominated by Moraxella spp. is associated with respiratory health in the elderly population: a case control study

Research

Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016

Research

Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis

Research

A comparison of four different models of acute respiratory distress syndrome in sheep

Research

Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case–control study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits